Notable 13F Reporting: As St Jude Med INC (STJ) Market Valuation Rose, Holder Vertex One Asset Management INC Has Trimmed Stake by $3.56 Million

Notable 13F Reporting: As St Jude Med INC (STJ) Market Valuation Rose, Holder Vertex One Asset Management INC Has Trimmed Stake by $3.56 Million

John Thiessen decreased its stake in St Jude Med Inc (STJ) by 10.25% based on its latest 2016Q3 regulatory filing with the SEC. Vertex One Asset Management Inc sold 45,000 shares as the company’s stock rose 1.94% with the market. The hedge fund run by John Thiessen held 394,077 shares of the health care company at the end of 2016Q3, valued at $31.43M, down from 439,077 at the end of the previous reported quarter. Vertex One Asset Management Inc who had been investing in St Jude Med Inc for a number of months, seems to be less bullish one the $ market cap company. The stock last traded at $0 per share. It is down 3.26% since June 1, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Vertex One Asset Management of John Thiessen had been created in 1997 and as stated by the company itself, it searches for “growth, value and event driven opportunities in fixed income and equity.” Vertex One Asset Management searches for companies that are misvalued and having a catalyst sometimes in the near future, while at the same time giving attention to valuation related to industry peers.

Insitutional Activity: The institutional sentiment decreased to 0.69 in Q3 2016. Its down 0.17, from 0.86 in 2016Q2. The ratio is negative, as 65 funds sold all STJ shares owned while 222 reduced positions. 51 funds bought stakes while 148 increased positions. They now own 229.40 million shares or 10.50% less from 256.31 million shares in 2016Q2. Arrow Capital Mgmt Ltd owns 5,000 shares or 0.51% of their US portfolio. Highbridge Mngmt Ltd Liability Co accumulated 150,512 shares or 0.19% of the stock. Eagle Asset Mngmt accumulated 379,914 shares or 0.21% of the stock. Ig Invest Mngmt holds 0% or 13,496 shares in its portfolio. Moreover, Zweig has 1.11% invested in St Jude Medical Inc (NYSE:STJ) for 171,536 shares. Retail Bank Of Nova Scotia holds 0.06% of its portfolio in St Jude Medical Inc (NYSE:STJ) for 130,754 shares. Denver Investment Advsr reported 10,321 shares or 0.04% of all its holdings. Aviva Public Ltd Company reported 175,142 shares or 0.09% of all its holdings. Apg Asset Nv reported 382,678 shares or 0.05% of all its holdings. Washington Trust Natl Bank accumulated 0.03% or 1,539 shares. Gluskin Sheff And Assoc, a Ontario – Canada-based fund reported 34,070 shares. Cap International Sarl has 58,315 shares for 0.39% of their US portfolio. The Ontario – Canada-based Canada Pension Plan Investment Board has invested 0.21% in St Jude Medical Inc (NYSE:STJ). First Corp In last reported 385 shares in the company. Boltwood Cap last reported 14,360 shares in the company.

Analysts await St Jude Medical Inc (NYSE:STJ) to report earnings on January, 25. They expect $1.07 EPS, up 4.90% or $0.05 from last year’s $1.02 per share. After $0.99 actual EPS reported by St Jude Medical Inc for the previous quarter, Wall Street now forecasts 8.08% EPS growth.

More notable recent St Jude Medical Inc (NYSE:STJ) news were published by: Businesswire.com which released: “St. Jude Medical Announces Cybersecurity Updates” on January 09, 2017, also Reuters.com with their article: “Abbott gets US antitrust approval to buy St. Jude Medical” published on December 27, 2016, Finance.Yahoo.com published: “Abbott Completes the Acquisition of St. Jude Medical” on January 04, 2017. More interesting news about St Jude Medical Inc (NYSE:STJ) were released by: Finance.Yahoo.com and their article: “Blog Coverage Abbott and St. Jude Medical Merger Gets OK from US and China’s …” published on January 03, 2017 as well as Equitiesfocus.com‘s news article titled: “St. Jude Medical, Inc. (NYSE:STJ) 50-day MA At $79.81” with publication date: January 11, 2017.

St Jude Medical Inc (NYSE:STJ) Ratings Coverage

Out of 20 analysts covering St. Jude Medical Inc. (NYSE:STJ), 4 rate it a “Buy”, 0 “Sell”, while 16 “Hold”. This means 20% are positive. St. Jude Medical Inc. has been the topic of 45 analyst reports since July 21, 2015 according to StockzIntelligence Inc. RBC Capital Markets maintained it with “Sector Perform” rating and $66 target price in Thursday, October 22 report. The firm earned “Sector Perform” rating on Monday, January 25 by RBC Capital Markets. The stock of St Jude Medical Inc (NYSE:STJ) has “Outperform” rating given on Thursday, October 22 by Credit Suisse. Stifel Nicolaus downgraded St Jude Medical Inc (NYSE:STJ) on Thursday, October 22 to “Hold” rating. As per Monday, July 11, the company rating was downgraded by Leerink Swann. The stock has “Buy” rating given by BTIG Research on Sunday, September 6. Suntrust Robinson downgraded the stock to “Neutral” rating in Tuesday, May 10 report. The stock of St Jude Medical Inc (NYSE:STJ) earned “Hold” rating by Zacks on Monday, August 24. The stock of St Jude Medical Inc (NYSE:STJ) has “Perform” rating given on Thursday, January 28 by Oppenheimer. The rating was maintained by Deutsche Bank on Saturday, August 29 with “Hold”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz